{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:33:51Z","timestamp":1765280031803,"version":"3.46.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,26]]},"DOI":"10.1515\/pp-2018-0119","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T18:16:19Z","timestamp":1529518579000},"source":"Crossref","is-referenced-by-count":5,"title":["In search of evidence \u2013 PIPAC on the fast lane"],"prefix":"10.1515","volume":"3","author":[{"given":"Martin","family":"H\u00fcbner","sequence":"first","affiliation":[{"name":"Department of Visceral Surgery , Lausanne University Hospital CHUV , Bugnon 46 , Lausanne 1011 , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"2025120909215699338_j_pp-2018-0119_ref_001_w2aab3b7b6b1b6b1ab1b4b1Aa","doi-asserted-by":"crossref","unstructured":"Horton R. Surgical research or comic opera: questions, but few answers. Lancet 1996;347:984\u20135.10.1016\/S0140-6736(96)90137-38606606","DOI":"10.1016\/S0140-6736(96)90137-3"},{"key":"2025120909215699338_j_pp-2018-0119_ref_002_w2aab3b7b6b1b6b1ab1b4b2Aa","doi-asserted-by":"crossref","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004;22:3284\u201392.10.1200\/JCO.2004.10.01215310771","DOI":"10.1200\/JCO.2004.10.012"},{"key":"2025120909215699338_j_pp-2018-0119_ref_003_w2aab3b7b6b1b6b1ab1b4b3Aa","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Clarke L. The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. Eur J Surg Oncol 2006;32:637\u201343.10.1016\/j.ejso.2006.03.00616630703","DOI":"10.1016\/j.ejso.2006.03.006"},{"key":"2025120909215699338_j_pp-2018-0119_ref_004_w2aab3b7b6b1b6b1ab1b4b4Aa","doi-asserted-by":"crossref","unstructured":"Verwaal VJ, Van Ruth S, De Bree E, Van Sloothen GW, Van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737\u201343.10.1200\/JCO.2003.04.18714551293","DOI":"10.1200\/JCO.2003.04.187"},{"key":"2025120909215699338_j_pp-2018-0119_ref_005_w2aab3b7b6b1b6b1ab1b4b5Aa","doi-asserted-by":"crossref","unstructured":"Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Maspero F, et al. FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials. Clin Colorectal Cancer 2013;12:145\u201351.10.1016\/j.clcc.2013.04.00623763824","DOI":"10.1016\/j.clcc.2013.04.006"},{"key":"2025120909215699338_j_pp-2018-0119_ref_006_w2aab3b7b6b1b6b1ab1b4b6Aa","doi-asserted-by":"crossref","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010;28:63\u20138.10.1200\/JCO.2009.23.928519917863","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"2025120909215699338_j_pp-2018-0119_ref_007_w2aab3b7b6b1b6b1ab1b4b7Aa","doi-asserted-by":"crossref","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 2016;17:1709\u201319.2774392210.1016\/S1470-2045(16)30500-9","DOI":"10.1016\/S1470-2045(16)30500-9"},{"key":"2025120909215699338_j_pp-2018-0119_ref_008_w2aab3b7b6b1b6b1ab1b4b8Aa","doi-asserted-by":"crossref","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016;27:1386\u2013422.10.1093\/annonc\/mdw23527380959","DOI":"10.1093\/annonc\/mdw235"},{"key":"2025120909215699338_j_pp-2018-0119_ref_009_w2aab3b7b6b1b6b1ab1b4b9Aa","unstructured":"http:\/\/abstracts.asco.org\/214\/AbstView_214_222851.html Consulted 11 Jun 2018."},{"key":"2025120909215699338_j_pp-2018-0119_ref_010_w2aab3b7b6b1b6b1ab1b4c10Aa","doi-asserted-by":"crossref","unstructured":"Jaaback K, Johnson N, Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2016;CD005340. doi:10.1002\/14651858.CD005340.pub426755441","DOI":"10.1002\/14651858.CD005340.pub4"},{"key":"2025120909215699338_j_pp-2018-0119_ref_011_w2aab3b7b6b1b6b1ab1b4c11Aa","doi-asserted-by":"crossref","unstructured":"Van Driel WJ, Koole SN, Sonke GS. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018;378:1363\u20134.","DOI":"10.1056\/NEJMc1802033"},{"key":"2025120909215699338_j_pp-2018-0119_ref_012_w2aab3b7b6b1b6b1ab1b4c12Aa","doi-asserted-by":"crossref","unstructured":"Solass W, Kerb R, Murdter T, Giger-Pabst U, Strumberg D, Tempfer C, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 2014;21:553\u20139.10.1245\/s10434-013-3213-124006094","DOI":"10.1245\/s10434-013-3213-1"},{"key":"2025120909215699338_j_pp-2018-0119_ref_013_w2aab3b7b6b1b6b1ab1b4c13Aa","doi-asserted-by":"crossref","unstructured":"Tempfer CB, Giger-Pabst U, Seebacher V, Petersen M, Dogan A, Rezniczek GA. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol 2018 May 6. Epub ahead of print. DOI:10.1016\/j.ygyno.2018.05.00129743140","DOI":"10.1016\/j.ygyno.2018.05.001"},{"key":"2025120909215699338_j_pp-2018-0119_ref_014_w2aab3b7b6b1b6b1ab1b4c14Aa","doi-asserted-by":"crossref","unstructured":"Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study. Eur J Surg Oncol 2018;44:991\u20136.10.1016\/j.ejso.2018.02.01429526367","DOI":"10.1016\/j.ejso.2018.02.014"},{"key":"2025120909215699338_j_pp-2018-0119_ref_015_w2aab3b7b6b1b6b1ab1b4c15Aa","doi-asserted-by":"crossref","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, H\u00fcbner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 2017;104:669\u201378.10.1002\/bjs.1052128407227","DOI":"10.1002\/bjs.10521"},{"key":"2025120909215699338_j_pp-2018-0119_ref_016_w2aab3b7b6b1b6b1ab1b4c16Aa","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=PIPAC&term=&cntry=&state=&city=&dist=. Consulted 11 Jun 2018."},{"key":"2025120909215699338_j_pp-2018-0119_ref_017_w2aab3b7b6b1b6b1ab1b4c17Aa","doi-asserted-by":"crossref","unstructured":"Graversen M, Detlefsen S, Asmussen J, Mahdi B, Fristrup C, Pfeiffer P, et al. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy \u2013 PIPAC-OPC2. Pleura and Peritoneum 2018;3. DOI: https:\/\/doi.org\/10.1515\/pap-2018-0108.","DOI":"10.1515\/pp-2018-0108"},{"key":"2025120909215699338_j_pp-2018-0119_ref_018_w2aab3b7b6b1b6b1ab1b4c18Aa","doi-asserted-by":"crossref","unstructured":"Graversen M, Detlefsen S, Asmussen J, Mahdi B, Fristrup C, Pfeiffer P, et al. Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients \u2013 study protocol for the PIPAC-OPC3 trial. A prospective, controlled phase 2 study. Pleura and Peritoneum 2018;3. DOI: https:\/\/doi.org\/10.1515\/pap-2018-0107.","DOI":"10.1515\/pp-2018-0107"},{"key":"2025120909215699338_j_pp-2018-0119_ref_019_w2aab3b7b6b1b6b1ab1b4c19Aa","doi-asserted-by":"crossref","unstructured":"Eveno C, Jouvin I, Pocard M, EstoK PIPAC. 01: pressurized Intraperitoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study. Pleura and Peritoneum 2018;3. DOI: https:\/\/doi.org\/10.1515\/pap-2018-0116.","DOI":"10.1515\/pp-2018-0116"},{"key":"2025120909215699338_j_pp-2018-0119_ref_020_w2aab3b7b6b1b6b1ab1b4c20Aa","doi-asserted-by":"crossref","unstructured":"Goetze TO, Al-Batran SE, Pabst U, Reymond M, Tempfer C, Bechstein WO, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo na\u00efve upper GI-adenocarcinomas with peritoneal seeding \u2013 A phase II\/III trial of the AIO\/CAOGI\/ACO. Pleura and Peritoneum 2018;3. DOI: https:\/\/doi.org\/10.1515\/pap-2018-0113.","DOI":"10.1515\/pp-2018-0113"},{"key":"2025120909215699338_j_pp-2018-0119_ref_021_w2aab3b7b6b1b6b1ab1b4c21Aa","doi-asserted-by":"crossref","unstructured":"Ceelen W, Van De Sande L, Graversen M, H\u00fcbner M, Pocard M, Reymond M, et al. Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane\u2122) for peritoneal carcinomatosis from upper GI, breast, or ovarian cancer \u2013 a phase I first-in-human study. Pleura and Peritoneum 2018;3. DOI: https:\/\/doi.org\/10.1515\/pap-2018-0112.","DOI":"10.1515\/pp-2018-0112"},{"key":"2025120909215699338_j_pp-2018-0119_ref_022_w2aab3b7b6b1b6b1ab1b4c22Aa","doi-asserted-by":"crossref","unstructured":"Ergina PL, Barkun JS, McCulloch P, Cook JA, Altman DG. IDEAL Group. IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ 2013.346:f3011.10.1136\/bmj.f301123778426","DOI":"10.1136\/bmj.f3011"},{"key":"2025120909215699338_j_pp-2018-0119_ref_023_w2aab3b7b6b1b6b1ab1b4c23Aa","doi-asserted-by":"crossref","unstructured":"McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK. IDEAL Group. IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 2013.346:f3012.10.1136\/bmj.f3012","DOI":"10.1136\/bmj.f3012"},{"key":"2025120909215699338_j_pp-2018-0119_ref_024_w2aab3b7b6b1b6b1ab1b4c24Aa","doi-asserted-by":"crossref","unstructured":"Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A. IDEAL Group. IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 2013.346:f2820.10.1136\/bmj.f2820","DOI":"10.1136\/bmj.f2820"},{"key":"2025120909215699338_j_pp-2018-0119_ref_025_w2aab3b7b6b1b6b1ab1b4c25Aa","doi-asserted-by":"crossref","unstructured":"H\u00fcbner M, Grass F, Teixeira-Farinha H, Pache B, Mathevet P, Demartines N. Pressurized IntraPeritoneal Aerosol Chemotherapy \u2013 Practical aspects. Eur J Surg Oncol 2017;43:1102\u20139.2843189610.1016\/j.ejso.2017.03.019","DOI":"10.1016\/j.ejso.2017.03.019"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/3\/2\/article-20180119.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0119\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:53:11Z","timestamp":1765277591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0119\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6,12]]},"published-print":{"date-parts":[[2018,6,26]]}},"alternative-id":["10.1515\/pp-2018-0119"],"URL":"https:\/\/doi.org\/10.1515\/pp-2018-0119","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"type":"electronic","value":"2364-768X"},{"type":"print","value":"2364-7671"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"article-number":"20180119"}}